FDA-approved COVID-19 vaccines will continue to be covered without cost-share for Members when administered by in-network Providers. When COVID-19 vaccine doses are provided by the government without charge, MVP will only reimburse for the administration of the vaccine.
For Medicare Products, FDA-approved COVID-19 vaccines administered by in-network Providers shall be covered without cost-share for Members under Medicare Part B benefit as a preventive vaccine; this coverage has been made permanent through CARES Act. For OON administrations, cost-share will be applied effective May 12, 2023. There are no out-of-country vaccine coverage benefits.